These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 5726781)

  • 1. The effects of drugs inhibiting catecholamine uptake on tyramine and noradrenaline-induced contractions of the isolated rat vas deferens.
    Barnett A; Symchowicz S; Taber RI
    Br J Pharmacol; 1968 Nov; 34(3):484-92. PubMed ID: 5726781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cocaine and imipramine on tyramine-induced release of noradrenaline-3H from the rat vas deferens in vitro.
    Barnett A; Staub M; Symchowicz S
    Br J Pharmacol; 1969 May; 36(1):79-84. PubMed ID: 5768130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the paradoxical lack of responsiveness of the guinea-pig vas deferens to tyramine.
    Rand MJ; Story DF; Dowding T
    J Auton Pharmacol; 1989 Oct; 9(5):315-28. PubMed ID: 2613734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the blocking effect of alpha-adrenoceptor antagonist drugs towards directly and indirectly acting agonists on the rat vas deferens.
    Lucchelli A; Santagostino-Barbone MG; D'Agostino G; Grana E
    Pharmacol Res Commun; 1983 Mar; 15(3):267-80. PubMed ID: 6134294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.
    Finberg JP; Tenne M
    Br J Pharmacol; 1982 Sep; 77(1):13-21. PubMed ID: 6127132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselectivity of catecholamines: differential effects of cocaine and desipramine on catecholamine-induced contractions of the rat isolated vas deferens.
    Park BK; Haynes BP; Sheridan SA; Nowell PT
    J Pharm Pharmacol; 1983 Jun; 35(6):373-7. PubMed ID: 6135776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered alpha-adrenergic responses of vas deferens to noradrenaline and tyramine from rats with short- and long-term alloxan diabetes.
    Oztürk Y; Yildizoğlu-Ari N; Altan VM
    Gen Pharmacol; 1994 Nov; 25(7):1519-24. PubMed ID: 7896069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of desipramine in the vas deferens and potentiation of noradrenaline response.
    Binini R; Bonaccorsi A; Garattini S; Morselli PL; Muscettola GB
    Br J Pharmacol; 1971 Feb; 41(2):390P-391P. PubMed ID: 5572290
    [No Abstract]   [Full Text] [Related]  

  • 9. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
    Docherty JR
    Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):49-57. PubMed ID: 24074250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1972 Dec; 227(2):433-56. PubMed ID: 4345926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serotonin paradox: drug-receptor interaction in rat vas deferens.
    Jurkiewicz A; do Carmo LG; Yomura MH; Jurkiewicz NH
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):210-4. PubMed ID: 10797863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the contractile responses of the rat vas deferens to cocaine and tetracaine.
    Vohra MM
    Can J Physiol Pharmacol; 1970 Jul; 48(7):490-7. PubMed ID: 5430354
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of ethacrynic acid on the guinea-pig and rat isolated vas deferens.
    Khoyi MA; Pousti A; Zarrindast MR
    Br J Pharmacol; 1974 Dec; 52(4):579-84. PubMed ID: 4455332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of presynaptic alpha-2-adrenoceptor and opioid receptor agonist responses in the rat vas deferens by chronic imipramine treatment.
    Keith RA; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):412-9. PubMed ID: 2885761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mode of action of clonidine, a central hypotensive agent, analyzed by the interaction with various sympathomimetic agents].
    Ozawa H; Uematsu T
    Nihon Yakurigaku Zasshi; 1975 Apr; 71(3):273-84. PubMed ID: 1171051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and indirect actions of 5-hydroxytryptamine on the rat isolated vas deferens.
    Lucchelli A; Santagostino-Barbone MG; Modesto F; Grana E
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):236-51. PubMed ID: 6433824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of various sympathomimetic amines on the isolated stripped vas deferens of the guinea-pig.
    Nedergaard OA; Westermann E
    Br J Pharmacol; 1968 Nov; 34(3):475-83. PubMed ID: 4302376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new type of drug enhancement: increased maximum response to cumulative noradrenaline in the isolated rat vas deferens.
    Barnett A; Greenhouse DD; Taber RI
    Br J Pharmacol Chemother; 1968 May; 33(1):171-6. PubMed ID: 5660158
    [No Abstract]   [Full Text] [Related]  

  • 19. Pre- and postsynaptic effects of p-tyramine and p-octopamine in the prostatic portion of the rat vas deferens.
    Celuch SM; Juorio AV
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):39-46. PubMed ID: 2907098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro denervation of the rat vas deferens through hypothermic storage.
    Jurkiewicz NH; Garcia AG; Jurkiewicz A
    Br J Pharmacol; 1992 Oct; 107(2):610-5. PubMed ID: 1422602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.